Bank of New York Mellon’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-657,974
| Closed | -$75K | – | 4289 |
|
|
2018
Q4 | $75K | Sell |
657,974
-395,766
| -38% | -$260K | ﹤0.01% | 4009 |
|
|
2018
Q3 | $1.79M | Sell |
1,053,740
-1,236
| -0.1% | -$2.21K | ﹤0.01% | 2909 |
|
|
2018
Q2 | $1.84M | Sell |
1,054,976
-64,726
| -6% | -$112K | ﹤0.01% | 2897 |
|
|
2018
Q1 | $2.05M | Buy |
1,119,702
+37,859
| +3% | +$80K | ﹤0.01% | 2788 |
|
|
2017
Q4 | $2.41M | Sell |
1,081,843
-89,215
| -8% | -$222K | ﹤0.01% | 2743 |
|
|
2017
Q3 | $3.4M | Buy |
1,171,058
+11,147
| +1% | +$38K | ﹤0.01% | 2527 |
|
|
2017
Q2 | $5.16M | Sell |
1,159,911
-75,510
| -6% | -$311K | ﹤0.01% | 2320 |
|
|
2017
Q1 | $5.76M | Buy |
1,235,421
+125,882
| +11% | +$730K | ﹤0.01% | 2261 |
|
|
2016
Q4 | $6.76M | Buy |
1,109,539
+66,577
| +6% | +$348K | ﹤0.01% | 2166 |
|
|
2016
Q3 | $5.75M | Buy |
1,042,962
+170,788
| +20% | +$800K | ﹤0.01% | 2175 |
|
|
2016
Q2 | $3.31M | Buy |
872,174
+240,196
| +38% | +$814K | ﹤0.01% | 2432 |
|
|
2016
Q1 | $1.74M | Sell |
631,978
-212,420
| -25% | -$769K | ﹤0.01% | 2733 |
|
|
2015
Q4 | $4.79M | Sell |
844,398
-18,186
| -2% | -$111K | ﹤0.01% | 2239 |
|
|
2015
Q3 | $4.57M | Buy |
862,584
+9,871
| +1% | +$76.4K | ﹤0.01% | 2285 |
|
|
2015
Q2 | $7.08M | Buy |
852,713
+220,257
| +35% | +$1.07M | ﹤0.01% | 2139 |
|
|
2015
Q1 | $2.92M | Buy |
632,456
+99,572
| +19% | +$324K | ﹤0.01% | 2613 |
|
|
2014
Q4 | $1.63M | Buy |
532,884
+26,820
| +5% | +$79.3K | ﹤0.01% | 3000 |
|
|
2014
Q3 | $1.41M | Buy |
506,064
+92,145
| +22% | +$334K | ﹤0.01% | 3095 |
|
|
2014
Q2 | $1.69M | Buy |
413,919
+28,303
| +7% | +$120K | ﹤0.01% | 3007 |
|
|
2014
Q1 | $2.05M | Buy |
385,616
+1,511
| +0.4% | +$8.47K | ﹤0.01% | 2867 |
|
|
2013
Q4 | $2.13M | Sell |
384,105
-26,449
| -6% | -$114K | ﹤0.01% | 2853 |
|
|
2013
Q3 | $1.85M | Buy |
410,554
+54,425
| +15% | +$244K | ﹤0.01% | 2890 |
|
|
2013
Q2 | $1.52M | Buy |
+356,129
| New | +$1.79M | ﹤0.01% | 2938 |
|
Other funds holding SGYP
Bank of New York Mellon's SGYP Position: Q1 2019 in Review
Bank of New York Mellon sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 657,974 shares — an estimated $75K sold.
Bank of New York Mellon first reported a position in SGYP in Q2 2013 and held it in 23 quarters. The position peaked at $7.08M in Q2 2015. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.
- Bank of New York Mellon reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
- Bank of New York Mellon sold 657,974 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $75K.
- Bank of New York Mellon first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 23 quarters.
- Bank of New York Mellon's Synergy Pharmaceuticals, Inc Common Stock position peaked at $7.08M in Q2 2015.
- 12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.
Based on Bank of New York Mellon's 13F filing for Q1 2019, filed 14 May 2019.